Successful outcome! One of many trials underway! Should make for an interesting webinar! Well done to all holders.
- Forums
- ASX - By Stock
- NEU
- Ann: P2 trial shows significant improvements in Phelan-McDermid
NEU
neuren pharmaceuticals limited
Add to My Watchlist
7.81%
!
$13.52

Ann: P2 trial shows significant improvements in Phelan-McDermid, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.52 |
Change
0.980(7.81%) |
Mkt cap ! $1.692B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $15.82M | 1.156M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 353 | $13.51 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.54 | 125 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15 | 13.480 |
10 | 198 | 13.470 |
3 | 149 | 13.460 |
3 | 237 | 13.450 |
2 | 797 | 13.440 |
Price($) | Vol. | No. |
---|---|---|
13.500 | 1205 | 4 |
13.510 | 526 | 3 |
13.520 | 1116 | 4 |
13.530 | 4230 | 8 |
13.540 | 1072 | 3 |
Last trade - 15.13pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online